Skip to main content

Table 1 Baseline characteristics of the study population grouped by the different coronary artery CTO lesions

From: The impact of successful chronic total occlusion percutaneous coronary intervention on long-term clinical outcomes in real world

Variable

LAD (n = 163)

LCX (n = 148)

RCA (n = 216)

 ≥ 2 vessel (n = 65)

P

Age (years)

64.74 ± 9.98

64.37 ± 10.23

64.66 ± 10.7

64.25 ± 11.67

0.982

Male

136 (83.4)

119 (80.4)

172 (79.6)

52 (80)

0.811

Days

7 (5,9)

6 (5,8)

7 (5,9)

7 (5,10.5)

0.291

BMI (kg/m2)

25.83 ± 3.3

26.25 ± 3.33

25.94 ± 3.37

26.16 ± 4.16

0.717

AC (cm)

93.14 ± 9.7

94.06 ± 10.08

93.32 ± 9.44

93.29 ± 12.11

0.868

Smoke

102 (62.6)

94 (63.5)

153 (70.8)

42 (64.6)

0.312

Drink

31 (19)

20 (13.5)

54 (25)

14 (21.5)

0.059

HT

113 (69.3)

112 (75.7)

162 (75)

47 (72.3)

0.553

DM

78 (47.9)

72 (48.6)

87 (40.3)

37 (56.9)

0.086

Hyperlipemia

91 (55.8)

92 (62.2)

118 (54.6)

35 (53.8)

0.486

CHD

94 (57.7)

88 (59.5)

140 (64.8)

40 (61.5)

0.525

OMI

32 (19.6)

29 (19.6)

56 (25.9)

16 (24.6)

0.375

HF

2 (1.2)

1 (0.7)

3 (1.4)

2 (3.1)

0.577

CKD

8 (4.9)

10 (6.8)

13 (6)

3 (4.6)

0.879

PAD

9 (5.5)

13 (8.8)

20 (9.3)

4 (6.2)

0.519

Stroke

36 (22.1)

38 (25.7)

42 (19.4)

12 (18.5)

0.486

History of PCI

49 (30.1)

48 (32.4)

64 (29.6)

19 (29.2)

0.94

History of CABG

3 (1.8)

2 (1.4)

8 (3.7)

10 (15.4)

< 0.001

ISR

15 (9.2)

5 (3.4)

17 (7.9)

2 (3.1)

0.104

PCI open

107 (68.2)

58 (40.6)

111 (53.9)

24 (42.1)

< 0.001

CABG

6 (3.7)

5 (3.4)

10 (4.6)

8 (12.3)

0.03

  1. Bold values indicate that the difference is statistically significant (p < 0.05)
  2. Data are presented as absolute numbers and percentages (for categorical variables) or mean value ± SD (for continuous variables) unless otherwise specified. BMI, body mass index; AC, Abdominal circumference; HT, hypertension; DM, diabetes mellitus; HF, heart failure; CHD, coronary heart disease; OMI, old myocardial infarction; CKD, Chronic kidney disease; PAD, Peripheral arterial disease; CABG, coronary artery bypass grafting; CTO, coronary chronic total occlusion; PCI, percutaneous coronary intervention; ISR, In stent restenosis